State support and the decisions taken by the government made it possible to correctly invest credit money so that the enterprise could operate and meet its obligations,” said Yuri Shuleiko.

The recent uptick in IPOs is an encouraging signal after a drought for much of 2025. Experts point to AI as a driving force ...

Mantis takes disparate sources of data to make synthetic datasets that can be used to build so-called "digital twins" of the human body, representing anatomy, physiology and behavior.

On Carilion Clinic announced the installation of Usability Works, a biotechnology engineering consultancy. As a part of ...

After entering 2026 hungry for deals, Gilead Sciences has wasted no time eating its fill. | After entering 2026 hungry for ...

A new tool makes it possible to screen millions of tiny protein fragments and select those that can be recognized by the ...

The programme aims to nurture emerging agri-biotech ventures through incubation and institutional collaboration ...

NARO had assigned Dr Kiggundu to chair a committee constituted to reposition NARO’s Laboratory Centre of Excellence at the ...

Innate Pharma has finally called time on an NK cell engager in phase 1/2 development as part of an ongoing fine-tuning of the French biotech’s pipeline. The Marseille-headquartered company had been ...

An unusually mild winter followed by a wet spring made last year one of the worst in a decade for Pennsylvania soybean ...

CRISPR Cas9 gene therapy explained with DNA scissors, hereditary diseases treatment, and designer babies ethical dilemmas ...

Shares of biotech Replimune Group sank more than 19% after the Food and Drug Administration rejected an application seeking ...